NCT07033598
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07033598
Title Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia (PROSPERA)
Acronym PROSPERA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Theradex
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
Winship Cancer Institute at Emory RECRUITING Atlanta Georgia 30322 United States Details
Mayo Clinic Rochester RECRUITING Rochester Minnesota 55905 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field